Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Visual Interface System for Improved Navigation and Accessibility Through EEG, Allowing for an EEG-driven Mobility Platform Offering Wheelchair-enabled Engagement and Rehabilitation (EMPOWER): An Early Feasibility Study (EFS) of Safety and Efficacy in Subjects With Severe Quadriplegia

NCT06169696 is registered in ClinicalTrials.gov with Synaptrix Labs Inc. as lead sponsor.

NCT NCT06169696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06169696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Visual Interface System for Improved Navigation and Accessibility Through EEG, Allowing for an EEG-driven Mobility Platform Offering Wheelchair-enabled Engagement and Rehabilitation (EMPOWER): An Early Feasibility Study (EFS) of Safety and Efficacy in Subjects With Severe Quadriplegia
Lead sponsor
Synaptrix Labs Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2024
Completion date
January 31, 2025
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis, cervical spinal cord injury, neurologic disorder, paralysis, paralysis; stroke, quadriplegia/tetraplegia, spinal cord injuries, tetraplegic; paralysis